M. Wilsey
Presidente presso SAREPTA THERAPEUTICS, INC.
Patrimonio netto: 28 M $ in data 30/04/2024
Profilo
La dottoressa M. K. Wilsey è presidente di MiMedx Group, Inc., amministratore indipendente di IGM Biosciences, Inc. e presidente di Sarepta Therapeutics, Inc. Fa parte del Consiglio di amministrazione di IGM Biosciences, Inc. La dottoressa Wilsey è stata precedentemente impiegata come direttore indipendente presso Amylin Pharmaceuticals, Inc., presidente e amministratore delegato presso KEW Group, Inc., membro del President's Council of Advisors on Science & Technology, Director-Science, Technology & Economic Policy presso The National Research Council, Managing Director presso RS Investment Management Co. LLC, presidente della National Venture Capital Association, amministratore delegato e socio generale della Robertson Stephens & Co. e cofondatore della Coalition for 21st Century Medicine. Ha anche fatto parte del consiglio di Abgenix, Inc. Si è laureata presso l'Università della California, Davis e ha conseguito un dottorato presso l'Università della California, Davis.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2024 | 184 993 ( 0.20% ) | 24 M $ | 30/04/2024 | |
IGM BIOSCIENCES, INC.
1.19% | 29/03/2024 | 400 359 ( 1.19% ) | 3 M $ | 30/04/2024 |
MIMEDX GROUP, INC.
0.11% | 13/06/2023 | 160 972 ( 0.11% ) | 1 M $ | 30/04/2024 |
Posizioni attive di M. Wilsey
| Società | Posizione | Inizio |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Presidente | 16/04/2015 |
| IGM BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 31/01/2019 |
| MIMEDX GROUP, INC. | Presidente | 19/06/2019 |
Precedenti posizioni note di M. Wilsey
| Società | Posizione | Fine |
|---|---|---|
Kew, Inc.
 Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Amministratore Delegato | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 08/08/2012 |
RS Investment Management Co. LLC
 RS Investment Management Co. LLC Investment ManagersFinance RS Investment Management Co. LLC (also known as RS Investments) is an investment advisor and mutual fund manager headquartered in San Francisco, California. Founded in 1986, the firm was acquired by Victory Capital Management, Inc. from The Guardian Life Insurance Co. of America in July 2016. They operate as an independent franchise within Victory Capital's multi-boutique model. Each of the teams within the RS franchise continues to operate autonomously. RS Investments provides investment advisory services to mutual funds, institutions, private pooled investment vehicles, and high net-worth individuals. | Corporate Officer/Principal | 01/12/2009 |
| President's Council of Advisors on Science & Technology | Corporate Officer/Principal | 01/01/2009 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Direttore/Membro del Consiglio | - |
Formazione di M. Wilsey
| University of California, Davis | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| IGM BIOSCIENCES, INC. | Health Technology |
| MIMEDX GROUP, INC. | Health Technology |
| Aziende private | 9 |
|---|---|
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| Robertson Stephens & Co. | Finance |
The National Research Council
 The National Research Council Miscellaneous Commercial ServicesCommercial Services The National Research Council provides science, technology and health policy consulting and advice. The company was founded in 1916 and is headquartered in Washington, DC. | Commercial Services |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Commercial Services |
RS Investment Management Co. LLC
RS Investment Management Co. LLC Investment ManagersFinance RS Investment Management Co. LLC (also known as RS Investments) is an investment advisor and mutual fund manager headquartered in San Francisco, California. Founded in 1986, the firm was acquired by Victory Capital Management, Inc. from The Guardian Life Insurance Co. of America in July 2016. They operate as an independent franchise within Victory Capital's multi-boutique model. Each of the teams within the RS franchise continues to operate autonomously. RS Investments provides investment advisory services to mutual funds, institutions, private pooled investment vehicles, and high net-worth individuals. | Finance |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Kew, Inc. provides oncology services. It provides multiple services to oncologists to assist in treatment decisions for cancer patients and offers genomic testing for patient tumor samples and genomic information important to diagnostic and treatment decisions that assist physicians and are detailed in cancer-specific Therapeutic Pathways. The company was founded by Richard Bohmer, Viren Mehta, Clayton Matt Christensen, Jeffrey Elton, Mason Freeman, John P. Glaser, H. Robert Horvitz, Bruce Johnson, Kathy Behrens Wilsey and Raju S. Kucherlapat in 2009 and is headquartered in Cambridge, MA. | Health Services |
| The Coalition for 21st Century Medicine | |
| President's Council of Advisors on Science & Technology | Government |
- Borsa valori
- Insiders
- M. Wilsey